Article info
PDFClinical
Original research
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial
- Correspondence to Dr Gillian Dean, Department of Sexual Health & HIV, Brighton and Sussex University Hospitals NHS Trust, Brighton, E Sussex, UK; gillian.dean2{at}nhs.net
Citation
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial
Publication history
- Received February 9, 2020
- Revised September 1, 2020
- Accepted September 27, 2020
- First published November 13, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (16 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.